ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

NIH, NCI Get Higher Funding In 2014 Budget

January 17, 2014

HHS Carcinogen Guidelines Draft

June 6, 1980

Shubick Committee Support New System for NCU Review, Action On Chemicals

November 14, 1975

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011

Oncology Groups Oppose Proposed Cuts In Medicare Payments For Cancer Drugs

October 11, 2002

NCI Launches NCORP with 53 Grants Totaling $465 Million

August 8, 2014